Innovation Meets Oncology: AMERIA Joins the Forschungscampus M²OLIE Mission

Based at Universitätsmedizin Mannheim, M²OLIE is setting a bold new standard in cancer care: to treat patients with metastatic cancer in just one working day. The initiative’s vision is nothing less than revolutionary – bringing diagnosis, decision-making, and individualized therapy into a seamless closed-loop process supported by advanced technology, digitalization, and interdisciplinary expertise.

‍

A New Front-End for Interventional Radiology

With our breakthrough laptop MAVERICK^AI, AMERIA contributes a critical building block to this ambitious mission:

• Advanced MRI and CT data visualization in 3D – delivering an intuitive, immersive understanding of complex medical imaging.
• Touchfree, sterile interaction – enabling physicians to operate seamlessly in clinical environments without compromising sterility.
• Broad AI applications in healthcare – making clinical workflows faster, safer, and more precise.

‍

By placing intuitive, voice- and gesture-based interaction at the center of interventional radiology, MAVERICK^AI empowers clinicians to focus fully on patients, while the technology adapts to their needs.

‍

Collaborating Across Science, Medicine, and Industry

The strength of M²OLIE lies in its ecosystem of excellence. Over 120 experts from academia, clinical practice, and industry are working hand in hand to rethink cancer treatment from the ground up. We are honored to join a consortium that includes:

• Fraunhofer-Gesellschaft ( Fraunhofer IPA) – world leaders in applied research across health and engineering

• Siemens Healthineers – a global pioneer in medical technology and imaging innovation

• Carl Zeiss Meditec AG – advancing precision optics and visualization systems in healthcare

• Medical technology innovators including BEC ROBOTICS, C37, Elysia, Getinge, GMV, medicalvalues, Mint Medical, Polavis, QIT Systeme, KUKA, PROGEN, Rapid Medical, Smart Reporting, and Porsche Consulting.
• Clinical and research excellence from Universitätsmedizin Mannheim, Universität Mannheim, Universität Heidelberg , Universitätsklinkum Bonn, Technische Hochschule Mannheim, and Deutsches Krebsforschungszentrum

‍

Together, this unique alliance bridges the gap between cutting-edge research, industrial innovation, and clinical application.

‍

Learn more about the M²OLIE initiative:
www.m2olie.de
Forschungscampus M²OLIE – BMBF